Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Presentation TCT 2024

TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation

Presenter: Daniel Overduin

October 30, 2024

Presentation TCT 2024

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

Presenter: Dirk Jan van Ginkel

October 29, 2024

Presentation TCT 2024

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Presenter: Wilbert Bor

October 27, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Presenter: Claudio Cigalini

September 18, 2022

Presentation TCT 2019

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Presenter: Victor Alfonso Dias

September 28, 2019

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation

Safety and Efficacy of TAVR With Continuation of Oral Anticoagulation

April 18, 2019

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Presentation TCT 2016

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation

Presenter: John M. Lasala, Philippe Pibarot, Jürgen Rothe

October 31, 2016

Advertisement

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Continuation versus Interruption of Oral Anticoagulation during TAVI

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Safety and Efficacy of TAVR With Continuation of Oral Anticoagulation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content